Bicara Therapeutics Inc. Common Stock

BCAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$22.64+0.22%

2026-09-18

Financials

Valuation Metrics

Bicara Therapeutics Inc. Common Stock's Market Cap is $1.49B. At end of 2025 it was $928M. Ranked #2228 of 3,121 in US market (top 71%), #883 of 1,463 on NASDAQ (top 60%), #165 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 62%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.49B	US#2,228/3,121 Sec#165/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-185M	US—/3,121 Sec—/266
Total Assets	$512M	US#2,762/3,121 Sec#165/266
Net Assets	$469M	US#2,275/3,121 Sec#114/266
Value
P/B	3.17x	US#1,810/3,121 Sec#92/266
FCF Yield	-9.09%	US—/3,121 Sec—/266
Profitability
ROE	-39.54%	US#2,627/3,121 Sec#136/266
ROA	-36.19%	US#2,924/3,121 Sec#175/266
Financial Health
Debt Ratio	9.27%	US#102/3,121 Sec#48/266
Total Debt	$1M	US#2,983/3,121 Sec#243/266
FCF	$-135M	US#2,699/3,121 Sec#168/266
Cash	$97M	US#2,253/3,121 Sec#180/266
Current Ratio	11.59x	US#217/3,121 Sec#68/266
Performance
1Y Return	104.70%	US#200/3,121 Sec#61/266
1M Return	-12.45%	US#2,372/3,121 Sec#179/266
From 52W High	-26.94%	US#1,903/3,121 Sec#148/266
1Y MDD	-27.63%	US#1,248/3,121 Sec#75/266
Trading
Volume	750,567 shares	US#2,050/3,121 Sec#217/266
Trading Value	$17M	US#2,299/3,121 Sec#188/266
Per Share
EPS	$-2.82	US—/3,121 Sec—/266
BPS	$7.13	US#2,077/3,121 Sec#97/266